SHINGRIX INDICATION NOW APPROVED TO INCLUDE IMMUNOCOMPROMISED PATIENTS 18 YEARS AND OLDER
SHINGRIX is a vaccine indicated for prevention of herpes zoster (HZ) (shingles):
- in adults aged 50 years and older.
- in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy.
SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox).